These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15898963)

  • 1. GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid.
    Jonathan Ryves W; Dalton EC; Harwood AJ; Williams RS
    Bipolar Disord; 2005 Jun; 7(3):260-5. PubMed ID: 15898963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.
    Chen G; Huang LD; Jiang YM; Manji HK
    J Neurochem; 1999 Mar; 72(3):1327-30. PubMed ID: 10037507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
    Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB
    Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
    Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
    J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway.
    Boku S; Nakagawa S; Masuda T; Nishikawa H; Kato A; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Kusumi I
    Eur J Pharmacol; 2014 Jan; 723():425-30. PubMed ID: 24211784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
    Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
    Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.
    Leng Y; Wang Z; Tsai LK; Leeds P; Fessler EB; Wang J; Chuang DM
    Mol Psychiatry; 2015 Feb; 20(2):215-23. PubMed ID: 24468826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
    Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
    Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons.
    Park SW; Lee JG; Seo MK; Cho HY; Lee CH; Lee JH; Lee BJ; Baek JH; Seol W; Kim YH
    Bipolar Disord; 2015 May; 17(3):278-90. PubMed ID: 25307211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular cell biology of lithium.
    Williams R; Ryves WJ; Dalton EC; Eickholt B; Shaltiel G; Agam G; Harwood AJ
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):799-802. PubMed ID: 15494019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.
    Di Daniel E; Cheng L; Maycox PR; Mudge AW
    Mol Cell Neurosci; 2006; 32(1-2):27-36. PubMed ID: 16531065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells.
    Song N; Boku S; Nakagawa S; Kato A; Toda H; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):183-9. PubMed ID: 22484386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure.
    Eickholt BJ; Towers GJ; Ryves WJ; Eikel D; Adley K; Ylinen LM; Chadborn NH; Harwood AJ; Nau H; Williams RS
    Mol Pharmacol; 2005 May; 67(5):1426-33. PubMed ID: 15687223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
    Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
    Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for a common mechanism of mood stabilizers.
    Harwood AJ; Agam G
    Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on the pharmacological mechanism of the mood stabilizer--the changes of the rat brain concentrations of monoamines and their metabolites after the administration of Li, CBZ and VPA for 14 days].
    Ikeda R
    Yakubutsu Seishin Kodo; 1993 Oct; 13(5):295-307. PubMed ID: 8266739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling.
    Sutton LP; Rushlow WJ
    Neuroscience; 2011 Dec; 199():116-24. PubMed ID: 22001305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study.
    Peselow ED; Clevenger S; IsHak WW
    Int Clin Psychopharmacol; 2016 Jul; 31(4):218-23. PubMed ID: 26523730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activity.
    Kozlovsky N; Nadri C; Belmaker RH; Agam G
    Int J Neuropsychopharmacol; 2003 Jun; 6(2):117-20. PubMed ID: 12890304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Glycogen Content in Astrocytes via Cav-1/PTEN/AKT/GSK-3β Pathway by Three Anti-bipolar Drugs.
    Jia S; Li B; Huang J; Verkhratsky A; Peng L
    Neurochem Res; 2018 Aug; 43(8):1692-1701. PubMed ID: 29968232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.